Removal of Tonsils, Adenoids May Increase Stress-Related Disorders in Children, Teens
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 9, 2024 -- The surgical removal of tonsils or adenoids in young people is associated with an increased risk for subsequent stress-related disorders, according to a study published online Dec. 9 in JAMA Network Open.
Xue Xiao, M.D., Ph.D., from the First Affiliated Hospital of Guangxi Medical University in Nanning, China, and colleagues examined whether the surgical removal of tonsils or adenoids is associated with a subsequent risk for stress-related disorders in a cohort study using Swedish nationwide population and health registry data of all individuals born between Jan. 1, 1981, and Dec. 31, 2016. Individuals who had undergone surgical removal of tonsils or adenoids (exposed persons) were compared to matched unrelated unexposed individuals (population-matched cohort [83,957 exposed and 839,570 unexposed persons]) and to full siblings (sibling-matched cohort [51,601 exposed and 75,159 unexposed full siblings]).
The researchers found that exposed persons exhibited a higher subsequent risk for stress-related disorders compared with the unexposed population reference (hazard ratio, 1.43), particularly posttraumatic stress disorder (PTSD; hazard ratio, 1.55). In the sibling-matched cohort, the results were replicated (hazard ratios, 1.34 and 1.41 for any stress-related disorder and PTSD, respectively). The increased risk was observed irrespective of sex, age at surgery, time since surgery, parental educational attainment, or parental history of stress-related disorders.
"If our findings here are validated in future studies of independent study populations, mechanistic studies would be needed to disentangle the role of human tonsils and their diseases, via inflammation or other associated health conditions, in the development of psychiatric disorders in general and stress-related disorders specifically," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
THURSDAY, June 5, 2025 -- For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel...
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.